APA Issues Guideline on Delirium Prevention and Treatment
October 2, 2025
The American Psychiatric Association (APA) recently released update...
Read More
Lithium Deficiency and Alzheimer’s Disease: A Potential Modifiable Risk Factor
September 26, 2025
Recent research published in Nature has identified endogenous lithi...
Read More
Hearing Loss, Hearing Aid Use, and Neuropsychiatric Symptoms among Persons Living with Dementia
September 8, 2025
Neuropsychiatric symptoms such as depression, apathy, and agitation...
Read More
Benzgalantamine Approved For The Treatment Of Mild-To-Moderate Alzheimer’s Disease
June 27, 2025
The FDA has approved benzgalantamine, a novel oral prodrug of galan...
Read More
FDA Clears First Blood Test Used In Diagnosing Alzheimer’s Disease
May 28, 2025
The FDA has approved the first blood-based test to help diagnose Al...
Read More
Magnetic Stimulation to the Precuneus Shows Benefit in Alzheimer’s Patients
May 21, 2025
A recent study offers compelling clinical insights into the potenti...
Read More
Rheumatoid Arthritis Linked to Faster Cognitive Decline in Dementia Patient
March 21, 2025
Rheumatoid arthritis (RA) has been linked to an increased risk of d...
Read More
Alzheimer's Disease Awareness
November 13, 2024
During National Alzheimer’s Disease Awareness Month we’d like to hi...
Read More
Adult ADHD and Dementia
November 7, 2024
Every year NEI Fall Congress kicks off with multiple pre-conference...
Read More
Brief, Culturally Sensitive Screener Helps Primary Care Providers Diagnose Dementia
July 18, 2024
A brief and culturally fair cognitive assessment tool, paired with ...
Read More
FDA Approves New Alzheimer's Treatment
July 2, 2024
The U.S. Food and Drug Administration has approved a new treatment ...
Read More
Highlights from 2024 NEI Synapse: Memories in the Future: An Update on the Diagnosis and Treatment of Alzheimer’s Disease
April 18, 2024
In her 2024 NEI Synapse presentation, Dr. Dani Cabral enlightened t...
Read More